automated-hospital-room-disinfection-utilizing-novel-aerosolized

Automated Hospital Room Disinfection Utilizing a Novel Aerosolized Hydrogen Peroxide Microdroplet Disbursing Technology

Traditional, manual and UV disinfection methods have left gaps in achieving thorough whole-room disinfection for hard-to-reach or shadowed areas, ...

Little Colorado Medical Center

Keratoconus is the most common corneal dystrophy. It can cause loss of uncorrected and best-corrected visual acuity through ectasia (thinning) of the central or paracentral cornea, irregular corneal scarring, or corneal perforation. Disease onset usually occurs in the second to fourth decade of life, periods of peak educational attainment or career development. The condition is lifelong and sight-threatening. Corneal collagen crosslinking (CXL) using ultraviolet A (UVA) light applied to the cornea is the only treatment that has been shown to slow progression of disease. The original, more widely known technique involves application of UVA light to de-epithelialized cornea, to which a photosensitizer (riboflavin) is added topically throughout the irradiation process. Transepithelial CXL is a recently advocated alternative to the standard CXL procedure, in that the epithelium is kept intact during CXL. Retention of the epithelium offers the putative advantages of faster healing, less patient discomfort, faster visual rehabilitation, and less risk of corneal haze.

Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus.

Viruses cause about 80% of all cases of acute conjunctivitis. Human adenoviruses are believed to account for 65% to 90% of cases of viral conjunctivitis, or 20% to 75% of all causes of infectious keratoconjunctivitis worldwide. Epidemic keratoconjunctivitis (EKC) is a highly contagious subset of adenoviral conjunctivitis that has been associated with large outbreaks at military installations and at medical facilities. It is accompanied by severe conjunctival inflammation, watery discharge, and light sensitivity, and can lead to chronic complications such as corneal and conjunctival scarring with discomfort and poor quality of vision. Due to a lack of consensus on the efficacy of any pharmacotherapy to alter the clinical course of EKC, no standard of care exists, therefore many clinicians offer only supportive care.

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.

Diabetic retinopathy is a common complication of diabetes and a leading cause of visual impairment and blindness. Research has established the importance of blood glucose control to prevent development and progression of the ocular complications of diabetes. Concurrent blood pressure control has been advocated for this purpose, but individual studies have reported varying conclusions regarding the effects of this intervention.

Article	Year
Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus. The Cochrane database of systematic reviews\| PubMed ID: 33765359	2021
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis. The Cochrane database of systematic reviews\| PubMed ID: 35238405	2022
Blood pressure control for diabetic retinopathy. The Cochrane database of systematic reviews\| PubMed ID: 36975019	2023

Barbara Hawkins

Biography

JoVE Journal Publications

Other Publications